These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31367163)

  • 21. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.
    Huang ZM; Li W; Li S; Gao F; Zhou QM; Wu FM; He N; Pan CC; Xia JC; Wu PH; Zhao M
    J Immunother; 2013 Jun; 36(5):287-93. PubMed ID: 23719239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system.
    Yang T; Zhang W; Wang L; Xiao C; Wang L; Gong Y; Huang D; Guo B; Li Q; Xiang Y; Nan Y
    BMC Cancer; 2018 Oct; 18(1):984. PubMed ID: 30326865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic cell-cytokine killer combined with microwave ablation reduced recurrence for hepatocellular carcinoma compared to ablation alone.
    Wang L; Li X; Dong XJ; Yu XL; Zhang J; Cheng ZG; Han ZY; Liu FY; Yu J; Liang P
    Technol Health Care; 2024; 32(3):1819-1834. PubMed ID: 38393935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model.
    Lee DH; Nam JY; Chang Y; Cho H; Kang SH; Cho YY; Cho E; Lee JH; Yu SJ; Kim YJ; Yoon JH
    Cancer Biol Ther; 2017 Jan; 18(1):67-75. PubMed ID: 28055304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients.
    Ding M; Wang Y; Chi J; Wang T; Tang X; Cui D; Qian Q; Zhai B
    PLoS One; 2016; 11(12):e0168798. PubMed ID: 28006010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer.
    Du H; Yang J; Zhang Y
    BMC Cancer; 2020 Apr; 20(1):357. PubMed ID: 32345239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells.
    Qiu Y; Xu MB; Yun MM; Wang YZ; Zhang RM; Meng XK; Ou-Yang XH; Yun S
    World J Gastroenterol; 2011 Dec; 17(48):5260-6. PubMed ID: 22219594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
    Huang ZM; Lai CX; Zuo MX; An C; Wang XC; Huang JH; Ning E
    J Cancer Res Ther; 2020; 16(7):1603-1610. PubMed ID: 33565506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells.
    Wang Y; Wang Y; Mu H; Liu T; Chen X; Shen Z
    Mol Med Rep; 2015 May; 11(5):3361-7. PubMed ID: 25625609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment.
    Xie Y; Huang L; Chen L; Lin X; Chen L; Zheng Q
    World J Surg Oncol; 2017 Nov; 15(1):209. PubMed ID: 29179719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer.
    Niu LZ; Li JL; Zeng JY; Mu F; Liao MT; Yao F; Li L; Liu CY; Chen JB; Zuo JS; Xu KC
    World J Gastroenterol; 2013 Jun; 19(22):3473-80. PubMed ID: 23801841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.
    Yu X; Zhao H; Liu L; Cao S; Ren B; Zhang N; An X; Yu J; Li H; Ren X
    J Clin Immunol; 2014 Feb; 34(2):194-203. PubMed ID: 24337625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
    Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
    Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).
    Zhao Y; Qiao G; Wang X; Song Y; Zhou X; Jiang N; Zhou L; Huang H; Zhao J; Morse MA; Hobeika A; Ren J; Lyerly HK
    Clin Transl Oncol; 2019 Jun; 21(6):721-728. PubMed ID: 30374838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma.
    Hui D; Qiang L; Jian W; Ti Z; Da-Lu K
    Dig Liver Dis; 2009 Jan; 41(1):36-41. PubMed ID: 18818130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: a systematic review and meta-analysis.
    Chen R; Deng X; Wu H; Peng P; Wen B; Li F; Li F
    Int Immunopharmacol; 2014 Oct; 22(2):451-64. PubMed ID: 25073120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systematic review and meta-analysis.
    Wang H; Liu A; Bo W; Feng X; Hu Y; Tian L; Zhang H; Tang X
    Dig Liver Dis; 2016 Nov; 48(11):1275-1282. PubMed ID: 27481586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High number of PD-1 positive intratumoural lymphocytes predicts survival benefit of cytokine-induced killer cells for hepatocellular carcinoma patients.
    Chang B; Shen L; Wang K; Jin J; Huang T; Chen Q; Li W; Wu P
    Liver Int; 2018 Aug; 38(8):1449-1458. PubMed ID: 29356308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The long-term efficacy of cytokine-induced killer cellular therapy for hepatocellular carcinoma: a meta-analysis.
    Wang J; Shen T; Wang Q; Zhang T; Li L; Wang Y; Fang Y
    Immunotherapy; 2019 Oct; 11(15):1325-1335. PubMed ID: 31578914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.